<DOC>
	<DOC>NCT02224170</DOC>
	<brief_summary>The primary purpose of this study is to compare the effect of lidocaine and dexamethasone on postoperative quality of recovery after laparoscopic cholecystectomy</brief_summary>
	<brief_title>Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy</brief_title>
	<detailed_description />
	<mesh_term>Gallstones</mesh_term>
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>ASA III patients aged between 20 and 65 year undergoing laparoscopic cholecystectomy due to gallbladder polyp or asymptomatic gallstones without cholecystitis 1. Steroid therapy or immunocompromised patients 2. Diabetes mellitus 3. Allergy to lidocaine or dexamethasone 4. Severe renal dysfunction (serum creatinine more than 1.6mg/dl) 5. Severe liver disease ( liver enzymes more than two times normal values) 6. History of atrioventricular block 7. Have a difficulty in understanding QoR40 (40item qualityofrecovery scoring system) or Korean language 8. History of physicologic disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Dexamethasone</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Quality of Recovery</keyword>
	<keyword>Laparoscopic cholecystectomy</keyword>
</DOC>